Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s
Video

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Launching: Thursday 24th April 2025
 
ADVANCED SEARCH
Log in

Imprint

Springer Medizin Verlag GmbH
Heidelberger Platz 3
14197 Berlin 
Germany

Tel.: +49 6221 345-0
Email: info@springermedicine.com

Registered office: Berlin | District Court Berlin-Charlottenburg, HRB 167094 B

Managing Directors: Fabian Kaufmann, Dr. Cécile Mack, Dr. Hendrik Pugge
Bank details: Deutsche Bank AG, Berlin | IBAN: DE33 1007 0000 0588 2188 00 | BIC: DEUTDEBBXXX

VAT ID no. DE230026696


Neu-Isenburg branch:
Am Forsthaus Gravenbruch 5-7, 63263 Neu-Isenburg
Tel.: 0 6102 / 5060

Munich branch: 
Aschauer Str. 30, 81549 Munich
Tel.: 0 89 / 20 30 43 - 0

Heidelberg branch: 
Tiergartenstraße 17, 69121 Heidelberg
Tel.: 0 6221 / 4870


Responsible in accordance with § 18 Abs.2 Interstate Media Treaty (Medienstaatsvertrag):

Dr. Erik Heintz, Springer Medizin Verlag GmbH, Aschauer Straße 30, 81549 Munich

Springer Medizin Verlag GmbH is the provider of springermedicine.com, unless other companies are identified as providers within the meaning of the German Telemedia Act and/or responsible parties in accordance with § 18 paragraph 2 Interstate Media Treaty (Medienstaatsvertrag) in separately identified parts of the website.

Despite careful checking by the editors, no liability can be assumed for the correctness of the publications. Likewise, no liability is assumed for the content that can be accessed via external links or that is recognizably posted by third parties. 

The content provided on this website may not – in whole or in part – be reused, reprinted, posted on Internet-based services or networks of any kind, saved on digital storage media for purposes of distribution, or reproduced, distributed, made available to the public in any other manner or used for commercial purposes without prior written consent. The content of this website may therefore not be used to develop, train and/or enrich any AI systems, in particular generative AI systems. The use of the content for text and data mining is expressly reserved. Text and data mining is therefore only permitted to the extent that this is allowed by an explicit contractual or statutory provision.

This imprint also applies to the mobile applications "e.Medpedia" and "Facharzt-Training".

Out-of-court settlement of disputes: We do not engage in out-of-court settlements before consumer arbitration bodies. However, under the regulation (EU) 524/2013 we are obliged to inform you that the European Commission provides a platform for online dispute resolution, which is available at http://ec.europa.eu/consumers/odr/.

Information in accordance with Regulation (EU) 2022/2065 (Digital Services Act)

  • Central contact point in accordance with Art. 11 of Regulation (EU) 2022/2065 for authorities (authorities of the EU Member States, EU Commission and the European Digital Services Board): authority_contact@springermedicine.com Communication is possible in German and English.
  • Central contact point pursuant to Art. 12 of Regulation (EU) 2022/2065 for users of our online services: customer_contact@springermedicine.com
  • The rules on content moderation (action against unlawful and other unauthorized information) in accordance with Art. 14 of Regulation (EU) 2022/2065 can be found in our Terms of Use
  • Transparency reports pursuant to Art. 15 (1) and 24 (2) and the numbers of active users of online platforms pursuant to Art. 24 (1) of Regulation (EU) 2022/2065 can be found at www.springermedicine.com/transparencyreports
  • Notification and redress procedures in accordance with Article 16 of Regulation (EU) 2022/2065: Information on how to report illegal content can be found at www.springermedicine.com/reporting
  • You can access our internal complaint-handling system in accordance with Article 20 of Regulation (EU) 2022/2065 at reporting@springermedicine.com. Here you as a user or as a person/entity who has reported unlawful content can file a complaint against decisions on the following types of measures: removal, blocking or restriction of access to information; suspension or termination of service to users; suspension or termination of a user account; restriction of monetisation of content; or the decision not to take such measures.
  • Out-of-court dispute resolution: Out-of-court dispute settlement pursuant to Art. 21 of Regulation (EU) 2022/2065 applies only to users, including reporting persons or entities, who are affected by a content moderation decision under our Terms of Use, in connection with such decisions, as well as complaints that have not been resolved through the means of the internal complaint-handling system. The user can select a certified out-of-court dispute settlement body to conduct a dispute settlement procedure. The provider is obliged to cooperate with the selected dispute settlement body.